***Registration for this event is now closed, to enquire about registering please email laurabacchus@onenucleus.com***
Following a challenging 2022 in terms of investment levels, economic climate and a slowdown in M&A activity in the Life Sciences sector globally, our panel will discuss the 2023 outlook for UK Life Sciences. What might we expect in terms of Government support, deal activity and investors’ appetite? We hope that you can join us after the panel for networking and refreshments.
Programme
18.00 – Arrival and registration (Tea and Coffee)
18.30 – Panel Discussion: The UK Financial Landscape Shaping Life Sciences in 2023
Panel
Ralph Hughes, Vice President - Strategy, PharmaVentures
Karolina Zapadka, VC Investor, Parkwalk Advisors
David Mardle, Partner, Goodwin
Rob Dando, Corporate Finance Partner, MHA MacIntyre Hudson
19.30 - Networking and Light Refreshments
21.00 – Close
One Nucleus members: Free
Non-Members: £50 + VAT
Academics: please contact alicia@onenucleus.com
BioWednesday London: The UK Financial Landscape Shaping Life Sciences in 2023
London, E1 2EF
United Kingdom